National Coverage Analysis (NCA) for Abarelix for the Treatment of Prostate Cancer (CAG-00238N)
Select the ’Print Record’, ‘Add to Basket’ or ‘Email Record’ buttons to print the record, to add it to your basket or to email the record.
Kate Tillman
410-786-9252
Original Consideration for Abarelix for the Treatment of Prostate Cancer (this document)